secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001664710-25-000050
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Keros Therapeutics to Present at Bank of America 2025 Global Healthcare Conference
--------------------------------------------------------------------------------

- CEO Jasbir Seehra to participate in fireside chat on May 13, 2025 at 8:00 p.m. Eastern time
- Press release issued May 12, 2025 announcing the event via SEC Form 8-K
- Live webcast available at bofa.veracast.com; archived replay on Keros website for 90 days

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471025000050/0001664710-25-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471025000050/kros-20250512.htm
  HTML page:      https://secwatch.observer/filing/0001664710-25-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer